Shivaprakash M. Rudramurthy

Shivaprakash M. Rudramurthy publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Shivaprakash M. Rudramurthy sits on this spectrum.

Shivaprakash M. Rudramurthy D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Shivaprakash M. Rudramurthy sits on this spectrum.

Research.com Recognitions

• Fellow of the European Confederation of Medical Mycology (ECMM)
• Fellow of the European Confederation of Medical Mycology (ECMM)
• Fellow of the European Confederation of Medical Mycology (ECMM)

Best Publications

• Fungal rhinosinusitis: A categorization and definitional schema addressing current controversies

  Arunaloke Chakrabarti;David W. Denning;Berrylin J. Ferguson;Jens Ponikau

  596
  Citations

• Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor.

  Unknown

  479
  Citations

• Incidence, characteristics and outcome of ICU-acquired candidemia in India

  Arunaloke Chakrabarti;Prashant Sood;Shivaprakash M. Rudramurthy;Sharon Chen

  468
  Citations

• Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.

  Atul Patel;Ritesh Agarwal;Shivaprakash M. Rudramurthy;Manoj Shevkani

  431
  Citations

• The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus

  Arunaloke Chakrabarti;Ashim Das;Jharna Mandal;M. R. Shivaprakash

  405
  Citations

• A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India

  Atul Patel;Atul Patel;Harsimran Kaur;Immaculata Xess;Joy S. Michael

  386
  Citations

• A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment

  Hariprasath Prakash;Anup Kumar Ghosh;Shivaprakash Mandya Rudramurthy;Pankaj Singh

  369
  Citations

• Candida auris candidaemia in Indian ICUs: analysis of risk factors.

  Shivaprakash M. Rudramurthy;Arunaloke Chakrabarti;Raees A. Paul;Prashant Sood

  351
  Citations

• Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management

  Shivaprakash M. Rudramurthy;Raees A. Paul;Arunaloke Chakrabarti;Johan W. Mouton

  276
  Citations

• Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.

  Shivaprakash M. Rudramurthy;Shamanth A. Shankarnarayan;Sunil Dogra;Dipika Shaw

  255
  Citations

• Invasive zygomycosis in India: experience in a tertiary care hospital.

  Arunaloke Chakrabarti;Shiv Sekhar Chatterjee;A Das;Naresh Panda

  243
  Citations

• Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.

  Valliappan Muthu;Shivaprakash M Rudramurthy;Arunaloke Chakrabarti;Ritesh Agarwal

  210
  Citations

• Fungal endophthalmitis: fourteen years' experience from a center in India.

  Arunaloke Chakrabarti;M R. Shivaprakash;Ramandeep Singh;Bansidhar Tarai

  210
  Citations

• Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions.

  M. Biswal;S.M. Rudramurthy;N. Jain;A.S. Shamanth

  207
  Citations

• Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.

  R Herbrecht;J. Maertens;L. Baila;Michel Aoun

  206
  Citations

• Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India)

  Murlidhar Rajagopalan;Arun Inamadar;Asit Mittal;Autar K. Miskeen

  193
  Citations

• An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients

  C Viscoli;R Herbrecht;H Akan;L Baila

  183
  Citations

• Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses

  Unknown

  183
  Citations

• ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.

  Shivaprakash M Rudramurthy;Martin Hoenigl;Martin Hoenigl;Jacques F Meis;Oliver A Cornely

  180
  Citations

• Invasive aspergillosis in developing countries

  Arunaloke Chakrabarti;Shiv Sekhar Chatterjee;Ashim Das;M. R. Shivaprakash

  173
  Citations